1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZYG11A CTRPv2 pan-cancer AAC -0.12 0.002
mRNA ZXDC CTRPv2 pan-cancer AAC 0.094 0.009
mRNA ZSCAN26 CTRPv2 pan-cancer AAC -0.1 0.005
mRNA ZRSR1 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA ZNHIT6 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA ZNF821 CTRPv2 pan-cancer AAC -0.098 0.01
mRNA ZNF804A CTRPv2 pan-cancer AAC -0.11 0.003
mRNA ZNF781 CTRPv2 pan-cancer AAC -0.1 0.009
mRNA ZNF703 CTRPv2 pan-cancer AAC 0.13 0.001
mRNA ZNF697 CTRPv2 pan-cancer AAC 0.14 0.001
Download CSV